the ecog-acrin e2810 study: pazopanib for patients with mrcc
Published 5 years ago • 286 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
1:46
dr. bernard escudier on patients preferring pazopanib for metastatic renal cell carcinoma
-
1:51
pazopanib for progressive desmoid tumors
-
5:14
star: drug-free interval strategy for renal cell carcinoma
-
2:33
dr. hsieh discusses frontline treatment of kidney cancer with pazopanib and sunitinib
-
5:39
researcher comment: the ecog-acrin e2108 trial | seema khan
-
11:05
ea8211/soar research study for patients with kidney cancer
-
3:34
keynote-604 and ecog-acrin 5161 trials for es-sclc
-
5:03
ea2185 research study for patients with pancreatic cysts
-
1:36
trabectedin and pazopanib: an indirect comparison of their ability to treat lms
-
0:57
areas of unmet need for patients with advanced uc
-
1:06
exciting potential of pembrolizumab combined with axitinib for kidney cancer
-
3:05
emerging therapies for advanced kidney cancer
-
21:43
why combination therapy may be best for my kidney cancer elizabeth plimack, md, ms 10/11/19
-
2:22
dr. andreas du bois reviews maintenance pazopanib in ovarian cancer
-
1:23
checkmate 9er: nivolumab with cabozantinib in renal cell carcinoma
-
5:06
ea8143/prosper rcc clinical trial for renal cell carcinoma
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer
-
2:34
oncomap™ physician overview video
-
2:21
about ecog-acrin